JO
ORGO icon

John Overdeck’s Organogenesis Holdings ORGO Stock Holding History

John Overdeck’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Sell
11,461
-15,536
-58% -$38K ﹤0.01% 4972
2026
Q1 		$64K Sell
26,997
-239,663
-90% -$830K ﹤0.01% 4434
2025
Q4 		$1.38M Buy
266,660
+216,066
+427% +$1.05M ﹤0.01% 2715
2025
Q3 		$214K Sell
50,594
-100,029
-66% -$465K ﹤0.01% 3355
2025
Q2 		$551K Sell
150,623
-174,391
-54% -$650K ﹤0.01% 2546
2025
Q1 		$1.4M Sell
325,014
-57,392
-15% -$232K ﹤0.01% 1970
2024
Q4 		$1.22M Buy
382,406
+78,744
+26% +$264K ﹤0.01% 2048
2024
Q3 		$868K Buy
303,662
+36,257
+14% +$102K ﹤0.01% 2208
2024
Q2 		$749K Sell
267,405
-202,445
-43% -$543K ﹤0.01% 2154
2024
Q1 		$1.33M Sell
469,850
-87,203
-16% -$296K ﹤0.01% 1769
2023
Q4 		$2.28M Buy
557,053
+22,502
+4% +$63K 0.01% 1432
2023
Q3 		$1.7M Sell
534,551
-375,253
-41% -$1.19M ﹤0.01% 1521
2023
Q2 		$3.02M Sell
909,804
-114,604
-11% -$339K 0.01% 1181
2023
Q1 		$2.18M Buy
1,024,408
+246,470
+32% +$609K 0.01% 1335
2022
Q4 		$2.09M Sell
777,938
-232,805
-23% -$679K 0.01% 1303
2022
Q3 		$3.27M Buy
1,010,743
+223,495
+28% +$1.01M 0.01% 938
2022
Q2 		$3.84M Buy
787,248
+96,662
+14% +$595K 0.01% 883
2022
Q1 		$5.26M Sell
690,586
-162,743
-19% -$1.26M 0.02% 900
2021
Q4 		$7.88M Buy
853,329
+69,950
+9% +$743K 0.02% 920
2021
Q3 		$11.2M Buy
783,379
+159,483
+26% +$2.48M 0.02% 723
2021
Q2 		$10.4M Buy
623,896
+196,827
+46% +$3.67M 0.02% 782
2021
Q1 		$7.78M Buy
427,069
+247,585
+138% +$3.35M 0.02% 824
2020
Q4 		$1.35M Buy
+179,484
New +$852K ﹤0.01% 1772
2020
Q2 		– Sell
-46,761
Closed -$151K – 3369
2020
Q1 		$151K Sell
46,761
-38,487
-45% -$165K ﹤0.01% 2743
2019
Q4 		$410K Buy
+85,248
New +$540K ﹤0.01% 2953

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

John Overdeck's ORGO Position: Q2 2026 in Review

John Overdeck reduced its Organogenesis Holdings (ORGO) stake by 58% in Q2 2026, selling an estimated $38K and leaving 11,461 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4972.

John Overdeck first reported a position in ORGO in Q4 2019 and has held it in 25 quarters since. The position peaked at $11.2M in Q3 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • John Overdeck held 11,461 shares of Organogenesis Holdings worth $27.9K as of Q2 2026.
  • John Overdeck sold 15,536 Organogenesis Holdings shares in Q2 2026, an estimated $38K.
  • Organogenesis Holdings made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4972 holding.
  • John Overdeck first reported a position in Organogenesis Holdings in Q4 2019 and has held it in 25 quarters since.
  • John Overdeck's Organogenesis Holdings position peaked at $11.2M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.